UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management

International journal of molecular sciences, 2023-12, Vol.25 (1), p.414

2023

Volltextzugriff (PDF)

Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung Cancer and Melanoma: A Systematic Review

International journal of molecular sciences, 2021-10, Vol.22 (21), p.11621

2021

Volltextzugriff (PDF)

A TIME-MIRRORING (TM) SCHEME FOR ICI MITIGATION IN TIME-VARYING CHANNEL FOR DIGITAL VIDEO BROADCASTING (DVB) SYSTEMS

Telecommunications & radio engineering, 2023, Vol.82 (3), p.1-16

2023

Volltextzugriff (PDF)

Dynamic association for load balancing and interference avoidance in multi-cell networks

IEEE transactions on wireless communications, 2009-07, Vol.8 (7), p.3566-3576

2009

Volltextzugriff (PDF)

Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis

Cell reports (Cambridge), 2022-11, Vol.41 (6), p.111611-111611, Article 111611

2022

Volltextzugriff (PDF)

Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study

Journal of clinical medicine, 2023-05, Vol.12 (11), p.3751

2023

Volltextzugriff (PDF)

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy

Frontiers in oncology, 2021-03, Vol.11, p.610303-610303

2021

Volltextzugriff (PDF)

Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis

Lung cancer (Amsterdam, Netherlands), 2019-08, Vol.134, p.127-140

2019

Volltextzugriff (PDF)

Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression

Frontiers in immunology, 2022-05, Vol.13, p.874589-874589

2022

Volltextzugriff (PDF)

Immunotherapy for head and neck cancer: Present and future

Critical reviews in oncology/hematology, 2022-06, Vol.174, p.103679-103679, Article 103679

2022

Volltextzugriff (PDF)

Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls

Current oncology reports, 2020-04, Vol.22 (4), Article 39

2020

Volltextzugriff (PDF)

The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives

Clinical immunology (Orlando, Fla.), 2021-05, Vol.226, p.108707-108707, Article 108707

2021

Volltextzugriff (PDF)

Reversing Immune Checkpoint Inhibitor–Associated Cardiotoxicity via Bioorthogonal Metabolic Engineering–Driven Extracellular Vesicle Redirecting

Advanced materials (Weinheim), 2024-11, Vol.36 (45), p.e2412340-n/a

2024

Volltextzugriff (PDF)

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

Frontiers in immunology, 2024-11, Vol.15

2024

Volltextzugriff (PDF)

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

Cancer cell, 2024-11, Vol.42 (11), p.1898-1918.e12

2024

Volltextzugriff (PDF)

E2‐mediated EMT by activation of β‐catenin/Snail signalling during the development of ovarian endometriosis

Journal of cellular and molecular medicine, 2019-12, Vol.23 (12), p.8035-8045

2019

Volltextzugriff (PDF)

Multimodal Imaging Response after the Singular or Combination Treatments of Vascular Endothelial Growth Factor Inhibitor and Immune Checkpoint Inhibitor

Molecular pharmaceutics, 2022-10, Vol.19 (10), p.3664-3672

2022

Volltextzugriff (PDF)

Perbandingan Kinerja Generalized Frequency Division Multiplexing Menggunakan Modulasi QAM dan Offset QAM

JNTETI (Jurnal Nasional Teknik Elektro dan Teknologi Informasi) (Online), 2023-02, Vol.12 (1), p.1-7

2023

Volltextzugriff (PDF)

Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group

Seminars in arthritis and rheumatism, 2023-02, Vol.58, p.152110-152110, Article 152110

2023

Volltextzugriff (PDF)

Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review

Cancer treatment reviews, 2023-09, Vol.119, p.102602-102602, Article 102602

2023

Volltextzugriff (PDF)

Intercarrier Interference Mitigation for Communication Compatible OFDM Radar

IEEE transactions on vehicular technology, 2024-04, Vol.73 (4), p.1-5

2024

Volltextzugriff (PDF)

Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center

International journal of cancer, 2021-05, Vol.148 (10), p.2502-2511

2021

Volltextzugriff (PDF)

Cutaneous immune-related adverse event burden and effect on immunotherapy: A retrospective review of the experience at a tertiary care immunotherapy center

Journal of the American Academy of Dermatology, 2024-03, Vol.90 (3), p.648-650

2024

Volltextzugriff (PDF)

Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model

Frontiers in immunology, 2024-03, Vol.15, p.1356144-1356144

2024

Volltextzugriff (PDF)

Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy

Lung cancer (Amsterdam, Netherlands), 2021-04, Vol.154, p.36-43

2021

Volltextzugriff (PDF)

1 – 25 von 3.136

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBritish Journal Of Pharmacology

SpracheSpanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.101)
Mit Volltextzugriff
(2.599)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.838)
Life Sciences & Biomedicine
(989)
Technology
(833)
Ici
(787)
Ofdm
(735)
Engineering
(682)
Engineering, Electrical & Electronic
(617)
Telecommunications
(554)
Interference
(461)
Humans
(390)
Orthogonal Frequency Division Multiplexing
(360)
Oncology
(328)
Immune Checkpoint Inhibitor
(285)
Immunotherapy
(283)
Animals
(254)
Immune Checkpoint Inhibitors
(224)
Male
(219)
Computer Science
(218)
Bit Error Rate
(212)
Biological And Medical Sciences
(203)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(1.316)
EZB Electronic Journals Library
(1.102)
IEEE Xplore
(882)
MEDLINE
(581)
IngentaConnect Journals
(557)
Journals@Ovid Full Text
(365)
Elsevier ScienceDirect Journals Complete
(344)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(260)
Springer journals
(206)
Wiley Journals
(151)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(124)
eBooks on EBSCOhost
(103)
Ebook Central Perpetual and DDA
(101)
Publisher or Other Site
(82)
Taylor & Francis Journals
(75)
Wiley Online Library Full Collection 2018
(73)
Nexis Uni
(67)
Taylor & Francis
(63)
Taylor & Francis Online
(45)
EBSCOhost Business Source Ultimate
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(8)
... seit 90 Tagen
(24)

Menü

Weitere Dienste

Einstellungen

Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management

Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung Cancer and Melanoma: A Systematic Review

A TIME-MIRRORING (TM) SCHEME FOR ICI MITIGATION IN TIME-VARYING CHANNEL FOR DIGITAL VIDEO BROADCASTING (DVB) SYSTEMS

Dynamic association for load balancing and interference avoidance in multi-cell networks

Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis

Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy

Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis

Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression

Immunotherapy for head and neck cancer: Present and future

Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls

The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives

Reversing Immune Checkpoint Inhibitor–Associated Cardiotoxicity via Bioorthogonal Metabolic Engineering–Driven Extracellular Vesicle Redirecting

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

E2‐mediated EMT by activation of β‐catenin/Snail signalling during the development of ovarian endometriosis

Multimodal Imaging Response after the Singular or Combination Treatments of Vascular Endothelial Growth Factor Inhibitor and Immune Checkpoint Inhibitor

Perbandingan Kinerja Generalized Frequency Division Multiplexing Menggunakan Modulasi QAM dan Offset QAM

Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group

Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review

Intercarrier Interference Mitigation for Communication Compatible OFDM Radar

Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center

Cutaneous immune-related adverse event burden and effect on immunotherapy: A retrospective review of the experience at a tertiary care immunotherapy center

Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model

Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy

Aktive Filter

Suchergebnisse filtern